Piper Sandler Downgrades Aurora Cannabis to Underweight, Lowers Price Target to $1

Piper Sandler analyst Michael Lavery downgrades Aurora Cannabis (NYSE:ACB) from Neutral to Underweight and lowers the price target from $3 to $1.